Lauran Neergaard

AP Medical Writer

I Stock 1396614976

J&J Says It Will Spend $2B to Expand Biopharmaceutical Manufacturing in U.S.

September 17, 2025

Investment Pr Header Image Abb Factory

ABB to Invest $110 Million in 4 U.S. Plants

September 17, 2025

Fall Protection Leads OSHA’s Top 10 Safety Violations for 15th Straight Year

September 17, 2025

CEO of Nvidia Jensen Huang speaks during a press conference at the Mandarin Oriental Qianmen after attending the third China International Supply Chain Expo, in Beijing, July 16, 2025.

Nvidia CEO Huang Says He's Disappointed by China Chip Curbs

September 17, 2025

This Wednesday, Dec. 23, 2020 file photo shows a vial of the Moderna COVID-19 vaccine in the first round of staff vaccinations at a hospital in Denver. On Thursday, Oct. 14, 2021, U.S. health advisers said that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus.

FDA Panel Endorses Lower-Dose Moderna COVID Shot for Booster

But there's no evidence that it's time to open booster doses of either the Moderna or Pfizer vaccine to everybody, the panel stressed.

October 15, 2021

In this May 19, 2021, file photo, a licensed practical nurse draws a Moderna COVID-19 vaccine into a syringe at a mass vaccination clinic at Gillette Stadium in Foxborough, Mass. Starting Thursday, Oct. 14, 2021, the Food and Drug Administration convenes its independent advisers for the first stage in the process of deciding whether extra shots of Moderna or Johnson & Johnson vaccines should be dispensed and, if so, who should get them and when.

Next on FDA's Agenda: Booster Shots of Moderna, J&J Vaccines

The panel will also look into the safety and effectiveness of mixing-and-matching different brands of vaccine.

October 12, 2021

In this Jan. 8, 2021, file photo, a pharmacist prepares a syringe of the Pfizer vaccine for COVID-19, at Queen Anne Healthcare, a skilled nursing and rehabilitation facility in Seattle. The U.S. vaccination drive against COVID-19 stood on the verge of a major new phase as government advisers Thursday, Sept. 23, recommended booster doses of Pfizer's vaccine for millions of older or otherwise vulnerable Americans — despite doubts the extra shots will do much to slow the pandemic.

CDC Adds People with Risky Jobs to COVID Booster List

The booster plan marks an important shift in the nation's vaccination drive.

September 24, 2021

In this file photo, staff members administer the AstraZeneca vaccine at La Nuvola (The Cloud) convention center that was temporarily turned into a COVID-19 vaccination hub in Rome.

AstraZeneca: US Data Shows Vaccine Effective for All Adults

Concerns about blood clots in European countries have also been addressed.

March 22, 2021

This Sept. 2020 photo provided by Johnson & Johnson shows a clinician preparing to administer investigational Janssen COVID-19 vaccine.

J&J 1-Dose Shot Works, Less Effective Than Others

It appears to protect against COVID-19, but not as strongly as some two-shot rivals.

January 29, 2021

In this file photo, empty vials of the Pfizer-BioNTech COVID-19 vaccine are seen at a vaccination center at the University of Nevada, Las Vegas in Las Vegas.

Why it's Hard to Make Vaccines and Boost Supplies

"It's not like adding more water to the soup."

January 28, 2021

Catalina Gonzalez-Marques, an emergency medical physician, receives the Pfizer-BioNTech coronavirus vaccine.

Health Officials Track Safety as COVID-19 Vaccines Roll Out

Vaccine recipients are supposed to hang around after the injection in case signs of an allergy appear.

December 17, 2020

Boxes containing the Pfizer-BioNTech COVID-19 vaccine are prepared to be shipped at the Pfizer Global Supply Kalamazoo manufacturing plant in Portage, Mich., Sunday, Dec. 13, 2020.

US Set for First COVID-19 Shots as Shipments Begin Arriving

Now the hurdle is to rapidly get vaccine into the arms of millions.

December 14, 2020

Blood samples from volunteers participating in the last-stage testing of the COVID-19 vaccine by Moderna and the National Institutes.

Years of Research Laid Groundwork for Speedy COVID-19 Shots

More than a decade of behind-the-scenes work is credited for the success.

December 8, 2020

The first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore.

UK Authorizes Pfizer Coronavirus Vaccine for Emergency Use

The company's shot is the first to be backed up by rigorous scientific review.

December 2, 2020

Nurse Kathe Olmstead prepares a shot that is part of a possible COVID-19 vaccine.

Moderna Asks US, European Regulators to OK its Vaccine

Study results suggest the vaccine is more than 94% effective.

November 30, 2020

Pedestrians walk past Pfizer world headquarters in New York.

Pfizer Seeking Emergency Use of its COVID-19 Vaccine in US

Limited first shots could start as early as next month.

November 20, 2020

In this July 27, 2020, file photo, nurse Kathe Olmstead prepares a shot that is part of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., in Binghamton, N.Y. Moderna said Monday, Nov. 16, 2020, its COVID-19 shot provides strong protection against the coronavirus that's surging in the U.S. and around the world.

2nd Vaccine Shows Overwhelming Success in US Tests

Moderna has added a second dash of hope in the global race for a shot.

November 16, 2020

I Stock 1205972800

Testing Timeline: What’s Ahead for COVID-19 Vaccines

Here's how the different shots will make it to market.

November 10, 2020

Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.

US Experts Vow 'No Cutting Corners' as Vaccine Tests Expand

Hopes are high that answers about at least one of several candidates could come by year's end.

September 24, 2020